ELAN
NYSE · Pharmaceuticals
Elanco Animal Health Inc
$23.65
-0.36 (-1.50%)
Performance
1D
—
1W
—
1M
—
3M
-4.75%
6M
+6.20%
1Y
+97.74%
YTD
+5.02%
Open$24.16
Previous Close$24.01
Day High$24.58
Day Low$22.91
52W High$27.72
52W Low$10.75
Volume—
Avg Volume6.30M
Market Cap11.81B
P/E Ratio—
EPS$-0.48
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$23.56
Above
SMA 200
$18.91
Above
RSI (14)
59.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+632.5% upside
Current
$23.65
$23.65
Target
$173.23
$173.23
$121.49
$173.23 avg
$230.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.74B | 4.64B | 2.45B |
| Net Income | -233,442,722 | -205,475,256 | 423.07M |
| Profit Margin | -4.9% | -4.7% | 17.2% |
| EBITDA | 544.30M | 505.71M | 874.42M |
| Free Cash Flow | — | — | 633.64M |
| Rev Growth | +2.3% | +2.3% | +2.6% |
| Debt/Equity | 0.61 | 0.61 | 0.94 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |